An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Clinical trial NCT06668181 · RECRUITING
Trial details
- NCT number
- NCT06668181
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-11
- Primary completion
- 2028-04-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.